Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index81
i10-index278
Publications794
Citations32,574

Grants

9 total · 1 active

NIH #U01FD007857

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$4M–$5M
Period
2023-09-01 → 2028-08-31
PIs
4

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #UH3CA260389

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$300K–$400K
Period
2021-06-01 → 2026-05-31
PIs
4

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #R01CA256157

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$600K–$700K
Period
2020-09-16 → 2025-12-31
PIs
3

Awarded at DUKE UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

9 total · 1 active

NIH #U01FD007857

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$4M–$5M
Period
2023-09-01 → 2028-08-31
PIs
4

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #UH3CA260389

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$300K–$400K
Period
2021-06-01 → 2026-05-31
PIs
4

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #R01CA256157

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$600K–$700K
Period
2020-09-16 → 2025-12-31
PIs
3

Awarded at DUKE UNIVERSITY

NIH #R21CA263950

Sieve based full likelihood approach for the Cox proportional hazards model with applications to immunotherapies trials

Amount
$200K–$300K
Period
2023-02-22 → 2025-01-31
PIs
2

Awarded at DUKE UNIVERSITY

NIH #R01CA249279

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Amount
$600K–$700K
Period
2021-09-01 → 2023-08-31
PIs
3

Awarded at UNIVERSITY OF MINNESOTA

NIH #UH2CA260389

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$100K–$200K
Period
2021-06-01 → 2023-05-31
PIs
4

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #R21CA195424

Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer

Amount
$200K–$300K
Period
2015-05-05 → 2018-04-30
PIs
2

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #U01CA157703

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$600K–$700K
Period
2011-09-26 → 2016-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #R01CA155296

Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate

Amount
$200K–$300K
Period
2011-07-06 → 2015-05-31
PIs
1

Awarded at DUKE UNIVERSITY

Recent Public Signals

  1. New paper: Supplementary Figure S5 from Evolution of <i>AR</i> and Non-<i>AR</i> Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial2026-06-15
  2. New NIH award: Research Triangle Center of Excellence in Regulatory Science and Innovation2023-09-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-4135-2777

Professor Insights

Career Trajectory